Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to ... survival and for terminal erythroid differentiation. Gene-edited mouse models are crucial for disease research but remain ...

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

Nov. 11, 2021 — A comprehensive study has shown that gene editing, specifically gene knockout (KO), with CRISPR-Cas9 can favor cells with mutated forms of genes linked to cancer. The findings ...

The North America CRISPR gene editing market is poised for substantial growth, with projections indicating a robust annual expansion of 24.4% throughout the forecast period. By 2031, it is anticipated ...

However, there are concerns that cutting the wrong gene or cutting too many times could cause genetic damage or new cancers. Peer and his team developed a CRISPR-Cas9 'delivery system' that uses ...

The study, published in Nucleic Acids Research, introduces BLU-VIPR, a method that allows researchers to control the gene ... RNA (gRNA) in cells, which then binds to Cas9, leading to the editing ...

The trials are the first to test a CRISPR/Cas9 gene editing therapy in humans for a genetic disease, according to the partners. The only available cure for both diseases is a bone marrow ...